35,000 Europeans will benefit from access to groundbreaking medical treatments if EU targets for attracting clinical trials are met.
EU healthcare systems and the wider economy would also benefit from an extra €4 billion a year in funding, the creation of 18,000 new jobs and the prevention of three million sick days, according to new research from Frontier Economics, published by EFPIA.
An 11% rise in trials is the new target set by the European Commission, European Medicines Agency and Heads of Medicines Agencies (HMA).
